文献速递临床试验与 GCP流行病学与生物统计

持续充气通气与间歇正压通气对极早产儿支气管肺发育不良或死亡的影响:SAIL随机临床试验

Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.
PubMed 文献 · JAMA · 2019-01-01

这项在9个国家18个新生儿重症监护病房开展的非盲随机临床试验,纳入需要复苏的23至26周极早产儿,比较持续充气通气与标准间歇正压通气对36周矫正胎龄时支气管肺发育不良或死亡的影响。持续充气组137例(63.7%)死亡或存活伴支气管肺发育不良,标准复苏组125例(59.2%),校正风险差4.7%(95%CI -3.8%至13.1%;P=0.29)。持续充气组48小时内死亡16例(7.4%),标准复苏组3例(1.4%),校正风险差5.6%(95%CI 2.1%至9.1%;P=0.002)。

要点

  • 持续充气通气未降低极早产儿36周矫正胎龄时支气管肺发育不良或死亡风险。
  • 持续充气组48小时内死亡16例(7.4%),标准复苏组3例(1.4%),校正风险差5.6%。
  • 盲法裁定发现早期死亡率失衡,持续充气组11/16例、标准复苏组1/3例可能归因于复苏。

核心结论

  • 在出生时需要复苏的极早产儿中,与标准间歇正压通气相比,包含2次持续充气的通气策略未降低36周矫正胎龄时支气管肺发育不良或死亡的风险。
  • 这些发现不支持在极早产儿中使用持续充气通气,但试验提前终止限制了确定性结论。

研究设计与样本

  • 非盲随机临床试验,2014年8月至2017年9月开展,随访至2018年2月15日。
  • 在9个国家的18个新生儿重症监护病房进行。
  • 纳入胎龄23至26周、需要复苏且呼吸努力不足或心动过缓的早产儿。
  • 计划纳入600例,在预设的不良结局审查后于纳入426例时终止试验。
  • 持续充气组215例,标准复苏组211例。

主要发现

  • 持续充气组137例(63.7%)死亡或存活伴支气管肺发育不良,标准复苏组125例(59.2%),校正风险差4.7%(95%CI -3.8%至13.1%;P=0.29)。
  • 持续充气组48小时内死亡16例(7.4%),标准复苏组3例(1.4%),校正风险差5.6%(95%CI 2.1%至9.1%;P=0.002)。
  • 盲法裁定检测到早期死亡率失衡,持续充气组11/16例、标准复苏组1/3例可能归因于复苏。
  • 27项次要疗效结局中,26项在36周矫正胎龄时组间无显著差异。

关键数值与推荐

  • 持续充气干预为使用T型管和面罩,最多2次持续充气,最大峰压25 cm H2O,每次15秒。
  • 标准复苏为间歇正压通气。
  • 主要结局为36周矫正胎龄时支气管肺发育不良或死亡的发生率。

临床怎么用

  • 原文结论指出这些发现不支持在极早产儿中使用持续充气通气,但试验提前终止限制了确定性结论。

局限性

  • 试验在纳入426例(计划600例)后提前终止,限制了确定性结论。
  • 原文指出早期终止试验限制了确定性结论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Preterm infants must establish regular respirations at delivery. Sustained inflations may establish lung volume faster than short inflations. OBJECTIVE: To determine whether a ventilation strategy including sustained inflations, compared with standard intermittent positive pressure ventilation, reduces bronchopulmonary dysplasia (BPD) or death at 36 weeks' postmenstrual age without harm in extremely preterm infants. DESIGN, SETTING, AND PARTICIPANTS: Unmasked, randomized clinical trial (August 2014 to September 2017, with follow-up to February 15, 2018) conducted in 18 neonatal intensive care units in 9 countries. Preterm infants 23 to 26 weeks' gestational age requiring resuscitation with inadequate respiratory effort or bradycardia were enrolled. Planned enrollment was 600 infants. The trial was stopped after enrolling 426 infants, following a prespecified review of adverse outcomes. INTERVENTIONS: The experimental intervention was up to 2 sustained inflations at maximal peak pressure of 25 cm H2O for 15 seconds using a T-piece and mask (n = 215); standard resuscitation was intermittent positive pressure ventilation (n = 211). MAIN OUTCOME AND MEASURES: The primary outcome was the rate of BPD or death at 36 weeks' postmenstrual age. There were 27 prespecified secondary efficacy outcomes and 7 safety outcomes, including death at less than 48 hours. RESULTS: Among 460 infants randomized (mean [SD] gestational age, 25.30 [0.97] weeks; 50.2% female), 426 infants (92.6%) completed the trial. In the sustained inflation group, 137 infants (63.7%) died or survived with BPD vs 125 infants (59.2%) in the standard resuscitation group (adjusted risk difference [aRD], 4.7% [95% CI, -3.8% to 13.1%]; P = .29). Death at less than 48 hours of age occurred in 16 infants (7.4%) in the sustained inflation group vs 3 infants (1.4%) in the standard resuscitation group (aRD, 5.6% [95% CI, 2.1% to 9.1%]; P = .002). Blinded adjudication detected an imbalance of rates of early death possibly attributable to resuscitation (sustained inflation: 11/16; standard resuscitation: 1/3). Of 27 secondary efficacy outcomes assessed by 36 weeks' postmenstrual age, 26 showed no significant difference between groups. CONCLUSIONS AND RELEVANCE: Among extremely preterm infants requiring resuscitation at birth, a ventilation strategy involving 2 sustained inflations, compared with standard intermittent positive pressure ventilation, did not reduce the risk of BPD or death at 36 weeks' postmenstrual age. These findings do not support the use of ventilation with sustained inflations among extremely preterm infants, although early termination of the trial limits definitive conclusions. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT02139800.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Kirpalani H, Ratcliffe SJ, Keszler M, et al. Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial. JAMA. 2019. PMID: 30912836. doi:10.1001/jama.2019.1660

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。